Switch theme
Sign up to access all valuation multiples
Cannabis Poland SA is engaged in the business of cannabis, wherein it supplies plant products containing cannabinoids for pharmaceutical industry.
2012
n/a
Last FY Revenue $0.1M
Last FY EBITDA -$0.6M
$4.0M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Cannabis Poland achieved revenue of $0.1M and an EBITDA of -$0.6M.
Cannabis Poland expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Cannabis Poland valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $0.1M | XXX | XXX | XXX |
| Gross Profit | XXX | $31K | XXX | XXX | XXX |
| Gross Margin | XXX | 47% | XXX | XXX | XXX |
| EBITDA | XXX | -$0.6M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -918% | XXX | XXX | XXX |
| EBIT | XXX | -$0.6M | XXX | XXX | XXX |
| EBIT Margin | XXX | -832% | XXX | XXX | XXX |
| Net Profit | XXX | -$0.6M | XXX | XXX | XXX |
| Net Margin | XXX | -862% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Cannabis Poland's stock price is PLN 0 (or $0).
Cannabis Poland has current market cap of PLN 17.8M (or $4.7M), and EV of PLN 15.0M (or $4.0M).
See Cannabis Poland trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4.0M | $4.7M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Cannabis Poland has market cap of $4.7M and EV of $4.0M.
Cannabis Poland's trades at 59.7x EV/Revenue multiple, and -6.5x EV/EBITDA.
Equity research analysts estimate Cannabis Poland's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cannabis Poland's P/E ratio is not available.
See valuation multiples for Cannabis Poland and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4.7M | XXX | $4.7M | XXX | XXX | XXX |
| EV (current) | $4.0M | XXX | $4.0M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 59.7x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -6.5x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -7.2x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -8.2x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -6.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCannabis Poland's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Cannabis Poland's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cannabis Poland's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Cannabis Poland and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -918% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 878% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cannabis Poland acquired XXX companies to date.
Last acquisition by Cannabis Poland was XXXXXXXX, XXXXX XXXXX XXXXXX . Cannabis Poland acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Cannabis Poland founded? | Cannabis Poland was founded in 2012. |
| Where is Cannabis Poland headquartered? | Cannabis Poland is headquartered in Poland. |
| Is Cannabis Poland publicy listed? | Yes, Cannabis Poland is a public company listed on WAR. |
| What is the stock symbol of Cannabis Poland? | Cannabis Poland trades under CBD ticker. |
| When did Cannabis Poland go public? | Cannabis Poland went public in 2013. |
| Who are competitors of Cannabis Poland? | Similar companies to Cannabis Poland include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Cannabis Poland? | Cannabis Poland's current market cap is $4.7M |
| Is Cannabis Poland profitable? | Yes, Cannabis Poland is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
